
Fundamentals for Newer Directors 2014 (pdf)
The latest edition of ICI’s flagship publication shares a wealth of research and data on trends in the investment company industry.
[32184]
January 29, 2020 TO: ICI Members
In December, the Hong Kong Securities and Futures Commission (“SFC”) published consultation conclusions (“Conclusion Paper”) on the Hong Kong over-the-counter (“OTC”) derivatives regime, implementing margin requirements for non-centrally cleared OTC derivative transactions.[1] The requirements are substantially similar to those proposed and address several comments that ICI Global raised in its comment letter on the proposal.[2] The initial margin (“IM”) requirements will be phased in starting on 1 September 2020 and the variation margin (“VM”) requirements will become effective on 1 September 2020.
Scope. As proposed, the IM and VM requirements will apply to all licensed persons who are contracting parties to non-centrally cleared OTC derivative transactions entered into with a “covered entity” (e.g., a registered fund).[3] In those cases, the parties must exchange IM when both the licensed person and the covered entity have an AANA of non-centrally cleared OTC derivatives exceeding HK$60 billion.[4] The parties must exchange VM when the licensed person itself or the consolidated group to which it belongs has an AANA of non-centrally cleared OTC derivatives exceeding HK$15 billion.[5]
In response to an ICI Global comment, the SFC clarified that, when determining the AANA threshold (and other thresholds), the SFC will evaluate each fund of an umbrella trust individually (and not the umbrella trust as a whole) as long as the fund is a distinct pool of assets:
Instruments Covered. The margin requirements will apply to all derivative transactions that a central counterparty does not clear,[7] except that:
In response to an ICI Global comment, the SFC clarified that the VM requirements for physically settled FX derivatives will not apply to funds.[9]
In addition, to address the legal uncertainty that jurisdictional differences in collateral arrangements create, the requirements will not require a licensed person to exchange: (i) IM or VM when there is reasonable doubt as to the enforceability of the netting agreement upon default or insolvency of the counterparty; or (ii) IM when there is reasonable doubtas to the enforceability of arrangements for the protection of posted collateral upon the default or insolvency of the counterparty.[10]
Computing IM. Parties must exchange IM under either: (i) a standardized margin schedule (“margin schedule approach”); or (ii) an internally developed, quantitative portfolio margin model (“model approach”).[11] The margin schedule approach is consistent with the BCBS-IOSCO margin requirements that the US prudential regulators and CFTC have adopted.[12] The model approach will require adherence to certain parameters and approval in writing from the SFC before it could be used.[13]
The margin requirements allow a licensed person in agreement with its counterparty to include non-centrally cleared OTC derivatives that are otherwise out of the scope of the margin requirements in the same netting set as the in-scope portfolio when calculating IM, as long as this is done consistently and on an ongoing basis.[14]
IM Threshold. The rules will permit a licensed person and a counterparty to agree not to exchange IM if the amount due is equal to or lower than HK$375 million. This amount is applied at the level of the consolidated group to which the licensed person and the counterparty belong and is based on all non-centrally cleared OTC derivatives outstanding between the two consolidated groups. A licensed person should have systems and controls in place to ensure that any allocated IM threshold is not exceeded.[15]
Treatment of IM. The rules will require a licensed person and its counterparty to each post IM collateral, as relevant. The licensed person, as collecting party, must:
The licensed person, as posting party, must ensure that IM posted:
If a third-party custodian is used, the licensed person also should ensure that:
IM collected from a counterparty may be rehypothecated, repledged or reused with a third party only for hedging the licensed person’s derivative positions arising out of transactions with the counterparty for which IM was collected and subject to certain conditions. The conditions, among other things, require a licensed person to obtain express written consent to the rehypothecation of the collateral.[16]
The rules will require the VM exchanged to fully collateralize the current exposure of the transaction, and VM will be calculated and exchanged for transactions subject to a single, legally enforceable netting agreement.
As with IM, a licensed person may agree with its counterparty to include non-centrally cleared OTC derivatives that are out of the scope of the margin requirements in the same netting set as the in-scope portfolio when calculating VM, as long as this is done consistently and on an ongoing basis.[17]
The rules will permit a licensed person to agree with its counterparty not to exchange margin if the amount of the margin due (aggregate of IM and VM) since the last exchange of margin is equal to or lower than a specified minimum transfer amount not exceeding HK$3.75 million.[18]
The rules will require IM to be called at the earliest time possible after either execution of a transaction or upon changes in measured potential future exposure. The IM for a given counterparty should be recalculated at least every 10 business days.
VM will be called at the earliest time possible after the trade date and from time to time thereafter. VM will be calculated at least daily.
The rules will require IM and VM to be collected as soon as practicable within the standard settlement cycle for the relevant collateral type.[19]
Eligible Margin. The rules allow the following collateral instruments to be eligible as margin for both IM and VM, subject to appropriate haircuts:
Haircuts. The rules will require that, when a licensed person collects IM or VM, it should ensure that the value of the collateral does not significantly correlate with the creditworthiness of the counterparty or the value of the underlying non-centrally cleared OTC derivatives portfolio in a way that will undermine the effectiveness of the margin protection. In addition, licensed persons will be required to have appropriate policies and procedures in place to monitor and manage concentration risk to ensure that the collateral collected as IM and VM is not overly concentrated in an individual issuer, issuer type, and asset type.[21]
The rules will employ haircuts to address market, foreign exchange, and other risks as well as volatility of the collateral market values under various conditions.[22] Haircuts will be applied to the market value of eligible collateral for margin purposes and will incorporate external credit ratings. Marketable debt securities must have an investment grade credit rating. When an external credit rating does not exist, a licensed person either must develop its own internal ratings-based approach or rely on a counterparty’s internal ratings.
Further, each party may designate only one currency in the documentation. Whenever the eligible collateral posted (as either IM or VM) is denominated in a currency other than the designated currency, there should be an additive haircut of 8 percent to the market value of any IM collateral (cash and non-cash) and non-cash VM collateral, except for onshore renminbi (CNY) and offshore renminbi (CNH), where the FX haircut should be 1.5 percent, to address the currency mismatch.[23]
The SFC will allow substituted compliance for those transactions with a counterparty that is subject to the margin requirements of another regulator or jurisdiction (“counterparty’s margin requirements”), if:
In response to a comment from ICI Global, the SFC explained that it plans on implementing an “outcomes-based” approach to determine comparability.[24] Regardless of whether the jurisdiction or regulator is a WGMR member, the SFC will critically review whether the requirements achieve outcomes which are substantively similar to the SFC’s margin requirements. The SFC also noted that HKMA’s current margin requirements are comparable to the SFC’s requirements, except the licensed person should be subject to the asset eligibility requirements and collateral haircuts the SFC imposes and that the licensed person must obtain approval in writing from the SFC before using any IM model, even if the HKMA approved the model. The SFC also noted that the list of jurisdictions and regulators whose margin regimes are deemed “comparable” will be published on the SFC’s website.[25]
The SFC will phase in the new IM and VM requirements as follows
Period
Threshold
IM
Phase-In
1 September 2020 to 31 August 2021
Both the licensed person and the covered entity have an AANA of non-centrally cleared OTC derivatives exceeding HK$375 billion on a group basis
Permanent
From 1 September 2021 for each subsequent 12-month period
Both the licensed person and the covered entity have an AANA amount of non-centrally cleared OTC derivatives exceeding HK$60 billion on a group basis
VM
1 September 2020
All parties subject to the rule, as described in Section I above
Kenneth Fang
Assistant General Counsel
Grace Socash
Legal Intern
[1] See SFC, Consultation Conclusions on the OTC derivatives regime for Hong Kong – Proposed margin requirements for non-centrally cleared OTC derivative transactions (December 2019), available at https://www.sfc.hk/edistributionWeb/gateway/EN/consultation/conclusion?refNo=18CP5.
[2] See Letter from Dan Waters, Managing Director, ICI Global, to Ashley Alder, Chief Executive Officer, Securities and Futures Commission (20 August 2018), available at https://www.ici.org/pdf/31340a.pdf.
[3] A “covered entity” is a financial counterparty, significant non-financial counterparty or other entity that the SFC designates. It does not include sovereigns, public-sector entities, multilateral development banks or the Bank for International Settlements. A “financial counterparty” is any of several listed entities (including collective investment schemes, such as mutual funds) that, with respect to a one-year period from 1 September through 31 August, has an average aggregate notional amount (“AANA”) of non-centrally cleared OTC derivatives exceeding HK$15 billion. See Conclusion Paper at Appendix A, Paragraphs 1-2.
[4] The AANA includes the gross notional amount of all non-centrally cleared OTC derivatives and is the average of the total gross notional amount of month-end positions of non-centrally cleared OTC derivatives for March, April, and May preceding the 1 September start date in a relevant year. See Conclusion Paper at Appendix A, Paragraph 4.
[5] A “consolidated group” is a group of entities for which consolidated financial statements are prepared. See Conclusion Paper at Appendix A, Paragraph 5.
[6] See Conclusion Paper at 7 and Appendix A, note 6.
[7] The margin requirements do not apply to derivative transactions that are centrally cleared if they: (i) are subject to the margin requirements of the central counterparty; or (ii) provide margin consistent with the relevant corresponding central counterparties margin requirements. See Conclusion Paper at Appendix A, Paragraph 7(a).
[8] See Conclusion Paper at Appendix A, Paragraph 7.
[9] See Conclusion Paper at Appendix A, note 9 (noting that the VM requirements for physically settled FX derivatives seek to “cover the asset manager, but not the funds managed by the manager”).
[10] See Conclusion Paper at Appendix A, Paragraphs 46-47. To take advantage of this exemption, the licensed person is expected to have assessed the enforceability of the netting agreement or the collateral arrangements, which should be supported by an external written legal opinion. See Conclusion Paper at Appendix A, Paragraph 48.
The SFC also exempts intragroup transactions (i.e., transactions between a licensed corporation and a covered entity in the consolidated group to which the licensed corporation also belongs) from the margin requirements, when:
See Conclusion Paper at Appendix A, Paragraph 49.
[11] When a licensed person does not face counterparty risk (e.g., if an option seller receives full payment of the premium upfront and does not have any potential future exposure to a counterparty), the licensed person may choose not to collect IM. These transactions may be excluded from the IM calculation. See Conclusion Paper at Appendix A, Paragraph 11 and note 12.
[12] See Conclusion Paper at Annex A (describing how to compute IM under the margin schedule approach).
[13] See Conclusion Paper at Annex B (setting forth parameters for the model approach). All models under the model approach will require, among other things, an estimate of the change in potential future exposure of the non-centrally cleared OTC derivatives to a one-tailed 99 percent confidence interval over a 10-day horizon, calibrated using three to five years of historical data, with at least 25 percent of this data from a period of significant financial stress. The model also should capture all relevant risk factors which materially influence the non-centrally cleared OTC derivative contracts in a netting set. At a minimum, the risk factors should include foreign exchange or interest rate risk, equity risk, credit risk and commodity risk. In addition, the model should appropriately assess other material risks arising from imperfect correlations, idiosyncratic risk of underlying credit, market liquidity and non-linear dependencies. Risk offsetting features should only be recognized within the same asset class and not across different asset classes.
[14] See Conclusion Paper at Appendix A, Paragraph 16.
[15] See Conclusion Paper at Appendix A, Paragraphs 18-21.
[16] See Conclusion Paper at Appendix A, Paragraphs 22-26.
[17] See Conclusion Paper at Appendix A, Paragraphs 27-30.
[18] See Conclusion Paper at Appendix A, Paragraphs 31-32.
[19] See Conclusion Paper at Appendix A, Paragraphs 33-36.
[20] The listed shares include:
See Conclusion Paper at Appendix A, Paragraph 37.
[21] See Conclusion Paper at Appendix A, Paragraphs 38-39.
[22] See Annex C (providing an eligible collateral haircut schedule).
[23] See Conclusion Paper at Appendix A, Paragraphs 41-45.
[24] See Conclusion Paper at 24.
[25] Id.
Latest Comment Letters:
TEST - ICI Comment Letter Opposing Sales Tax on Additional Services in Maryland
ICI Comment Letter Opposing Sales Tax on Additional Services in Maryland
ICI Response to the European Commission on the Savings and Investments Union